GYRE THERAPEUTICS, INC. Reports annual revenue of $113.5 million
Company Records $92.9 million loss
By USInMinutes
Published - Mar 28, 2024, 12:33 AM ET
Last Updated - Mar 28, 2024, 12:33 AM EDT
GYRE THERAPEUTICS, INC. [GYRE] has reported $113.5 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $92.9 million.
